|Day's Range||0.40 - 0.47|
|52 Week Range||0.40 - 3.26|
|PE Ratio (TTM)||-0.59|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CorMedix, Inc. Here are 5 ETFs with the largest exposure to CRMD-US. Comparing the performance and risk of CorMedix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis CorMedix, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of CorMedix, Inc. – Becton, Dickinson and Company, Emergent BioSolutions Inc., Utah Medical Products, Inc., Tetraphase Pharmaceuticals, Inc. and Achaogen, Inc. (BDX-US, EBS-US, UTMD-US, TTPH-US and AKAO-US) that have also ... Read more (Read more...)
Investors in CorMedix, Inc. (CRMD) need to pay close attention to the stock based on moves in the options market lately.